Sasha Ellis | VP, Corporate Affairs & IR |
Scott Braunstein | CEO, President & Director |
Christy Shafer | Chief Commercial Officer |
Joseph Hulihan | Chief Medical Officer |
Steven Pfanstiel | CFO & Treasurer |
Andrew Tsai | Jefferies |
Charles Duncan | Cantor Fitzgerald & Co. |
Douglas Tsao | H.C. Wainwright & Co. |
Jay Olson | Oppenheimer |
Michael Higgins | Ladenburg Thalmann & Co. |
Brian Skorney | Robert W. Baird & Co. |
Marc Goodman | SVB Securities |
Joon Lee | Truist Securities |
Jason Butler | JMP Securities |
Joseph Thome | Cowen and Company |
Greetings and welcome to the Marinus Pharmaceuticals Second Quarter 2022 Financial Results and Business Update Call. This time all participants are in listen-only mode. After the speakers' presentation there will be a question-and-answer session.
Now it is my pleasure to introduce your host, Sasha Ellis, Vice President of Corporate Affairs and Investor Relations.
You may begin Ms.